Foradil Aerolizer

Foradil Aerolizer is a brand name of formoterol, approved by the FDA in the following formulation(s):

FORADIL (formoterol fumarate - powder; inhalation)

• 
  Manufacturer: NOVARTIS
  
  Approval date: February 16, 2001
  
  Strength(s): 0.012MG/INH ^[RLD]

Has a generic version of Foradil Aerolizer been approved?

No. There is currently no therapeutically equivalent version of Foradil Aerolizer available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Foradil Aerolizer. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Powder inhaler
  Patent 6,488,027
  Issued: December 3, 2002
  Inventor(s): Claude; Moulin
  Assignee(s): Novartis AG
  This invention relates to single dose dry powder inhalers in which medicament is stored in a capsule and is released by piercing the capsule wall with polymer-coated steel pins. Methods of preparation of polymer-coated piercing means and their use in releasing the medicament from the capsule are described.
  
  Patent expiration dates:
  
  
  • March 8, 2019
    
  
  



• 
  Aerosol composition comprising formoterol
  Patent 6,887,459
  Issued: May 3, 2005
  Inventor(s): Haeberlin; Barbara
  Assignee(s): Novartis, AG
  The use of a dry powder comprising (A) formoterol, or a pharmaceutically acceptable salt or solvate thereof, or solvate of said salt, and (B) a pharmaceutically acceptable particulate diluent or carrier in an amount of from 400 μg to 5000 μg per μg of (A) for the preparation of an inhalable medicament for the treatment of chronic obstructive pulmonary disease.
  
  Patent expiration dates:
  
  
  • November 28, 2020
    
    ✓ 
    Patent use: TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
  
  

See also...

• Foradil Consumer Information (Drugs.com)
• Foradil Aerolizer Consumer Information (Wolters Kluwer)
• Foradil Aerolizer Consumer Information (Cerner Multum)
• Foradil Aerolizer Advanced Consumer Information (Micromedex)
• Foradil AHFS DI Monographs (ASHP)
• Formoterol Consumer Information (Wolters Kluwer)
• Formoterol Solution Consumer Information (Wolters Kluwer)
• Formoterol Consumer Information (Cerner Multum)
• Formoterol Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
• Formoterol Fumarate AHFS DI Monographs (ASHP)